Immunologic Response of Extremely Premature Infants to Tetanus, Haemophilus influenzae, and Polio Immunizations
1 Department of Pediatrics, Strong Children's Medical Center, University of Rochester, Rochester, NY
Objective. To determine whether extremely premature infants have immunologic responses to tetanus toxoid, Haemophilus influenzae type b polysaccharide and polio vaccines similar to those of full-term infants.
Infants and Methods. Sixteen extremely premature (<29 weeks, <1000 g at birth) infants received separate diphtheria-tetanus-pertussis and H influenzae type b oligosaccharide-CRM,197-conjugated (HbOC) vaccines at 2, 4 and 6 months of chronologic age, enhanced potency inactivated polio vaccine at 2 months, and oral polio vaccine at 4 months. Serum was obtained for anti-tetanus toxoid (TT), anti-Haemophilus b polysaccharide (HbPs) and polio neutralizing antibody assays before the 2-month vaccination and 4 to 6 weeks after the 6-month vaccination. Comparison sera were obtained from full-term infants immunized with the same lots of diphtheria-tetanus-pertussis (n = 46) and HbOC (n 66) vaccines or the same sequence of polio vaccines (n = 10).
Results. Preterm and full-term infants had similar geometric mean titers of anti-TT antibodies, anti-HbPs antibodies, and neutralizing antibodies to polio serotypes 1, 2, and 3 after the completion of the primary series of vaccines. After vaccination, similar proportions of preterm and full-term infants had protective levels of antibody to TT (preterm 100% vs full-term 100% with levels >0.01 IU/mL), HbPS (82% vs 87%, >1.0 µg/mL), and polio serotypes 1 (85% vs 80%,
1:8) and 2 (100% vs 100%,
1:8). Preterm infants were less likely than full-term infants to have protective levels of neutralizing antibody to polio serotype 3 (31% vs 90%,
1:8).
Conclusions. Extremely premature infants have adequate antibody responses to tetanus and HbOC antigens but may have diminished responsiveness to serotype 3 polio vaccine.
Submitted on December 21, 1994Accepted on March 1, 1995
This article has been cited by other articles:
![]() |
C. T. D'Angio, P. A. Boohene, A. Mowrer, S. Audet, M. A. Menegus, D. S. Schmid, and J. A. Beeler Measles-Mumps-Rubella and Varicella Vaccine Responses in Extremely Preterm Infants Pediatrics, March 1, 2007; 119(3): e574 - e579. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Omenaca, J. Garcia-Sicilia, P. Garcia-Corbeira, R. Boceta, and V. Torres Antipolyribosyl Ribitol Phosphate Response of Premature Infants to Primary and Booster Vaccination With a Combined Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Inactivated Polio Virus/Haemophilus influenzae Type b Vaccine Pediatrics, January 1, 2007; 119(1): e179 - e185. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Bonhoeffer, C-A Siegrist, and P T Heath Immunisation of premature infants Arch. Dis. Child., November 1, 2006; 91(11): 929 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Omenaca, J. Garcia-Sicilia, P. Garcia-Corbeira, R. Boceta, A. Romero, G. Lopez, and R. Dal-Re Response of Preterm Newborns to Immunization With a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B Virus-Inactivated Polio and Haemophilus influenzae Type b Vaccine: First Experiences and Solutions to a Serious and Sensitive Issue Pediatrics, December 1, 2005; 116(6): 1292 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Baley and E. G. Leonard The Immunologic Basis for Neonatal Immunizations NeoReviews, October 1, 2005; 6(10): e463 - e470. [Full Text] [PDF] |
||||
![]() |
M H Slack, S Cade, D Schapira, R J Thwaites, A Crowley-Luke, J Southern, R Borrow, and E Miller DT5aP-Hib-IPV and MCC vaccines: preterm infants' response to accelerated immunisation Arch. Dis. Child., April 1, 2005; 90(4): 338 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J Robinson, C. Heal, E. Gardener, P. Powell, and D. G. Sims Antibody Response to Diphtheria-Tetanus-Pertussis Immunization in Preterm Infants Who Receive Dexamethasone for Chronic Lung Disease Pediatrics, April 1, 2004; 113(4): 733 - 737. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H Slack, D Schapira, R J Thwaites, C Schapira, J Bamber, M Burrage, J Southern, N Andrews, and E Miller Acellular pertussis vaccine given by accelerated schedule: response of preterm infants Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2004; 89(1): F57 - F60. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Saari and and Committee on Infectious Diseases Immunization of Preterm and Low Birth Weight Infants Pediatrics, July 1, 2003; 112(1): 193 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
P T Heath, R Booy, J McVernon, J Bowen-Morris, H Griffiths, M P E Slack, A C Moloney, M E Ramsay, and E R Moxon Hib vaccination in infants born prematurely Arch. Dis. Child., March 1, 2003; 88(3): 206 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Clarke, P J Powell, D Goldblatt, and M J Robinson Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2003; 88(1): F58 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Nyambi, A. Nádas, H. A. Mbah, S. Burda, C. Williams, M. K. Gorny, and S. Zolla-Pazner Immunoreactivity of Intact Virions of Human Immunodeficiency Virus Type 1 (HIV-1) Reveals the Existence of Fewer HIV-1 Immunotypes than Genotypes J. Virol., November 15, 2000; 74(22): 10670 - 10680. [Abstract] [Full Text] |
||||
![]() |
M J Robinson, F Campbell, P Powell, D Sims, and C Thornton Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed., January 1, 1999; 80(1): 69F - 71. [Abstract] [Full Text] |
||||
![]() |
R. Khalak, M. E. Pichichero, and C. T. D'Angio Three-year Follow-up of Vaccine Response in Extremely Preterm Infants Pediatrics, April 1, 1998; 101(4): 597 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pourcyrous, S. B. Korones, D. Crouse, and H. S. Bada Interleukin-6, C-Reactive Protein, and Abnormal Cardiorespiratory Responses to Immunization in Premature Infants Pediatrics, March 1, 1998; 101 (3): e3 - e3. [Abstract] [Full Text] [PDF] |
||||









